| 1 |
33432521 | Co-delivery of doxorubicin and SIS3 by folate-targeted polymeric micelles for overcoming tumor multidrug resistance. | 2022 Jan |
1 |
| 2 |
33691545 | Sterols and triterpenoids from Ganoderma lucidum and their reversal activities of tumor multidrug resistance. | 2022 Mar |
1 |
| 3 |
34624510 | Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects. | 2022 Feb |
7 |
| 4 |
34719826 | Loperamide potentiates doxorubicin sensitivity in triple-negative breast cancer cells by targeting MDR1 and JNK and suppressing mTOR and Bcl-2: In vitro and molecular docking study. | 2022 Jan |
1 |
| 5 |
34844236 | Dysregulated MDR1 by PRDM1/Blimp1 Is Involved in the Doxorubicin Resistance of Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma. | 2022 |
3 |
| 6 |
34856211 | A natural product, voacamine, sensitizes paclitaxel-resistant human ovarian cancer cells. | 2022 Jan 1 |
1 |
| 7 |
34896572 | Repositioning application of polyoxyethylene (20) sorbitan monooleate on ocular drug resistance and cancer multi-drug resistance by inhibiting the ATPase activity of human multidrug resistance protein 1 and P-glycoprotein. | 2022 Jan |
2 |
| 8 |
34915026 | Dependence of ABCB1 transporter expression and function on distinct sphingolipids generated by ceramide synthases-2 and -6 in chemoresistant renal cancer. | 2022 Feb |
1 |
| 9 |
34978808 | Salidroside Promotes Sensitization to Doxorubicin in Human Cancer Cells by Affecting the PI3K/Akt/HIF Signal Pathway and Inhibiting the Expression of Tumor-Resistance-Related Proteins. | 2022 Jan 28 |
2 |
| 10 |
35075112 | Galectin-1 confers resistance to doxorubicin in hepatocellular carcinoma cells through modulation of P-glycoprotein expression. | 2022 Jan 24 |
3 |
| 11 |
35126877 | Phytic acid-modified CeO2 as Ca2+ inhibitor for a security reversal of tumor drug resistance. | 2022 |
4 |
| 12 |
35235816 | miR-200c increases the sensitivity of breast cancer cells to Doxorubicin through downregulating MDR1 gene. | 2022 Apr |
3 |
| 13 |
35279218 | Correction to: MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1). | 2022 Mar 12 |
1 |
| 14 |
35327403 | Infigratinib (BGJ 398), a Pan-FGFR Inhibitor, Targets P-Glycoprotein and Increases Chemotherapeutic-Induced Mortality of Multidrug-Resistant Tumor Cells. | 2022 Mar 3 |
3 |
| 15 |
35330134 | Interaction Analysis of MRP1 with Anticancer Drugs Used in Ovarian Cancer: In Silico Approach. | 2022 Mar 7 |
3 |
| 16 |
35450042 | Ribociclib Inhibits P-gp-Mediated Multidrug Resistance in Human Epidermoid Carcinoma Cells. | 2022 |
1 |
| 17 |
35450348 | C20-nor-Abietane and Three Abietane Diterpenoids from Plectranthus mutabilis Leaves as P-Glycoprotein Modulators. | 2022 Apr 14 |
4 |
| 18 |
35451580 | miR-205 Reverses MDR-1 Mediated Doxorubicin Resistance via PTEN in Human Liver Cancer HepG2 Cells. | 2022 Mar |
4 |
| 19 |
35582915 | Epifriedelanol enhances adriamycin-induced cytotoxicity towards K562/ADM cells by down regulating of P-gp and MRP2. | 2022 Apr |
1 |
| 20 |
35614289 | Bioactivity inspired C19-diterpenoid alkaloids for overcoming multidrug-resistant cancer. | 2022 May 25 |
1 |
| 21 |
32229058 | Isopetasin and S-isopetasin as novel P-glycoprotein inhibitors against multidrug-resistant cancer cells. | 2021 Jun |
2 |
| 22 |
33009882 | Ursolic acid reduces Adriamycin resistance of human ovarian cancer cells through promoting the HuR translocation from cytoplasm to nucleus. | 2021 Feb |
2 |
| 23 |
33189788 | Novel dendritic polyglycerol-conjugated, mesoporous silica-based targeting nanocarriers for co-delivery of doxorubicin and tariquidar to overcome multidrug resistance in breast cancer stem cells. | 2021 Feb 10 |
1 |
| 24 |
33411349 | CD44 enhances adriamycin resistance in chronic myelogenous leukaemia cells K562. | 2021 Oct |
1 |
| 25 |
33476826 | NO-releasing polypeptide nanocomposites reverse cancer multidrug resistance via triple therapies. | 2021 Mar 15 |
1 |
| 26 |
33598946 | miR-21 inhibition reverses doxorubicin-resistance and inhibits PC3 human prostate cancer cells proliferation. | 2021 Jun |
1 |
| 27 |
33725657 | Design, synthesis and bioactivity study on 5-phenylfuran derivatives as potent reversal agents against P-glycoprotein-mediated multidrug resistance in MCF-7/ADR cell. | 2021 Apr 15 |
1 |
| 28 |
33735724 | A novel flavonoid from Fissistigma cupreonitens, 5‑hydroxy‑7,8‑dimethoxyflavanone, competitively inhibited the efflux function of human P-glycoprotein and reversed cancer multi-drug resistance. | 2021 May |
1 |
| 29 |
33753859 | Nongenotoxic ABCB1 activator tetraphenylphosphonium can contribute to doxorubicin resistance in MX-1 breast cancer cell line. | 2021 Mar 22 |
7 |
| 30 |
33762953 | LINC01116 Promotes Doxorubicin Resistance in Osteosarcoma by Epigenetically Silencing miR-424-5p and Inducing Epithelial-Mesenchymal Transition. | 2021 |
1 |
| 31 |
33775688 | Nuclear factor-κB signaling inhibitors revert multidrug-resistance in breast cancer cells. | 2021 May 1 |
1 |
| 32 |
33808505 | Screening of Natural Compounds as P-Glycoprotein Inhibitors against Multidrug Resistance. | 2021 Mar 30 |
1 |
| 33 |
33917090 | Novel Pyrimidine Derivatives as Potential Anticancer Agents: Synthesis, Biological Evaluation and Molecular Docking Study. | 2021 Apr 7 |
2 |
| 34 |
33927626 | A New Chalcone Derivative C49 Reverses Doxorubicin Resistance in MCF-7/DOX Cells by Inhibiting P-Glycoprotein Expression. | 2021 |
1 |
| 35 |
33948366 | Binding of RNA m6A by IGF2BP3 triggers chemoresistance of HCT8 cells via upregulation of ABCB1. | 2021 |
1 |
| 36 |
33995950 | Effects of self-assembled cell-penetrating peptides and their nano-complexes on ABCB1 expression and activity. | 2021 Mar |
2 |
| 37 |
34000577 | Curcumin reverses doxorubicin resistance in colon cancer cells at the metabolic level. | 2021 Jul 15 |
4 |
| 38 |
34023560 | Hsa_circ_0092276 promotes doxorubicin resistance in breast cancer cells by regulating autophagy via miR-348/ATG7 axis. | 2021 Aug |
2 |
| 39 |
34031441 | The inhibition of ABCB1/MDR1 or ABCG2/BCRP enables doxorubicin to eliminate liver cancer stem cells. | 2021 May 24 |
6 |
| 40 |
34048174 | Expressions of P-Glycoprotein, Multidrug Resistance Protein 1 and Annexin A2 as Predictive Factors for Intravesical Recurrence of Bladder Cancer after the Initial Transurethral Resection and Immediate Single Intravesical Instillation of Adriamycin. | 2021 May 1 |
1 |
| 41 |
34069490 | Essential Oils, Pituranthos chloranthus and Teucrium ramosissimum, Chemosensitize Resistant Human Uterine Sarcoma MES-SA/Dx5 Cells to Doxorubicin by Inducing Apoptosis and Targeting P-Glycoprotein. | 2021 May 19 |
1 |
| 42 |
34094940 | Crizotinib and Doxorubicin Cooperatively Reduces Drug Resistance by Mitigating MDR1 to Increase Hepatocellular Carcinoma Cells Death. | 2021 |
3 |
| 43 |
34114067 | Oncolytic virotherapy reverses chemoresistance in osteosarcoma by suppressing MDR1 expression. | 2021 Sep |
4 |
| 44 |
34174351 | Self-assembled micelle responsive to quick NIR light irradiation for fast drug release and highly efficient cancer therapy. | 2021 Aug 10 |
1 |
| 45 |
34198967 | Cancer Stem-Like Phenotype of Mitochondria Dysfunctional Hep3B Hepatocellular Carcinoma Cell Line. | 2021 Jun 27 |
1 |
| 46 |
34286569 | TPGS-Galactose-Modified Polydopamine Co-delivery Nanoparticles of Nitric Oxide Donor and Doxorubicin for Targeted Chemo-Photothermal Therapy against Drug-Resistant Hepatocellular Carcinoma. | 2021 Aug 4 |
4 |
| 47 |
34336684 | STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1. | 2021 |
1 |
| 48 |
34354052 | Compound 968 reverses adriamycin resistance in breast cancer MCF-7ADR cells via inhibiting P-glycoprotein function independently of glutaminase. | 2021 Aug 5 |
1 |
| 49 |
34374660 | Algerian propolis: between protection of normal cells and potentialisation of the anticancer effects of doxorubicin against breast cancer cells via P-glycoprotein inhibition and cell cycle arrest in the S phase. | 2021 Apr |
1 |
| 50 |
34405014 | Suppression Of Aberrant Activation Of NF-κB Pathway In Drug-resistant Leukemia Stem Cells Contributes To Parthenolide-potentiated Reversal Of Drug Resistance In Leukemia. | 2021 |
1 |